Patents by Inventor Helene FAESSEL

Helene FAESSEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAK-925 FOR USE IN TREATING NARCOLEPSY
    Publication number: 20220339143
    Abstract: A method for treating narcolepsy type 1 in a subject in need thereof is disclosed, comprising administering to the subject an effective amount of methyl 3-((methylsulfonyl)anhino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate (Compound (I)), or a salt thereof, wherein plasma concentration for Compound (I) is about 5.04 ng/mL or more for about 1 hour or more. Compositions for treating narcolepsy type 1 comprising Compound (I) are also disclosed.
    Type: Application
    Filed: September 12, 2020
    Publication date: October 27, 2022
    Inventors: Deborah HARTMAN, Rebecca EVANS, Helene FAESSEL, Shinichiro TANAKA
  • USE OF AN OREXIN 2 RECEPTOR AGONIST FOR THE TREATMENT OF EXCESSIVE SLEEPINESS
    Publication number: 20220331303
    Abstract: Described herein are methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)-piperidine-1-carboxylate (Compound (I)), compositions comprising Compound (I), and the use of Compound (I) for the treatment of excessive sleepiness in a subject in need thereof.
    Type: Application
    Filed: September 12, 2020
    Publication date: October 20, 2022
    Inventors: Deborah HARTMAN, Rebecca EVANS, Helene FAESSEL, Robert RUBENS, Shinichiro TANAKA